At 3 months, findings showed 80.4% of patients treated with Juvéderm Voluma XC achieved at least a 1-point improvement in moderate to severe temple hollowing. The Food and Drug Administration (FDA) ...
(RTTNews) - Drug manufacturer AbbVie Inc. (ABBV), Tuesday announced that its subsidiary Allergan Aesthetics received approval from the U.S. Food and Drug Administration or FDA regarding Juvederm ...
JUVÉDERM® VOLUX™ XC IS THE FIRST AND ONLY HYALURONIC ACID (HA) FILLER TO RECEIVE U.S. FDA APPROVAL FOR IMPROVING JAWLINE DEFINITION IRVINE, Calif., Aug. 3, 2022 /PRNewswire/ -- Today, Allergan ...
The Food and Drug Administration has approved the hyaluronic acid dermal filler Juvéderm Voluma XC for injection in the temple region to improve moderate to severe temple hallowing in individuals over ...
VIRGINIA BEACH -- The world of facial rejuvenation, without surgery, just improved. That 'fast food' want-it-now mentality is finding its way into med spas and doctor's offices across the country with ...
Q. What are the differences between Sculptra and Voluma? Which one do you recommend? A. Sculpture and Voluma are both cosmetic treatments used for facial enhancement, but they differ significantly.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results